$AIMD
Ainos, Inc.

2019 Q2 Form 10-K Financial Statement

#000101476319000004 Filed on April 16, 2019

View on sec.gov

Income Statement

Concept 2019 Q2 2018 2017 Q4
Revenue $606.00 $77.72K $0.00
YoY Change 142.4% -69.03%
Cost Of Revenue $563.00 $64.88K $0.00
YoY Change -20.37% 7.56%
Gross Profit $43.00 $12.85K $0.00
YoY Change -109.41% -93.26%
Gross Profit Margin 7.1% 16.53%
Selling, General & Admin $405.0K $1.315M $180.0K
YoY Change 14.5% 70.69% -21.74%
% of Gross Profit 941762.79% 10235.32%
Research & Development $50.12K $32.59K
YoY Change
% of Gross Profit 116567.44% 253.69%
Depreciation & Amortization $17.90K
YoY Change 3.94%
% of Gross Profit 139.29%
Operating Expenses $455.1K $1.348M $180.0K
YoY Change 28.67% 74.92% -21.74%
Operating Profit -$455.0K -$1.335M -$180.0K
YoY Change 28.49% 130.21% -21.74%
Interest Expense $1.522K $3.963K -$30.00K
YoY Change 56.42% -89.46%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$450.0K -$1.340M -$210.0K
YoY Change 25.0% 116.13% -8.7%
Income Tax
% Of Pretax Income
Net Earnings -$453.5K -$1.339M -$210.0K
YoY Change 27.71% 116.83% -8.7%
Net Earnings / Revenue -74837.79% -1722.3%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.17 -$563.0K -$0.14
COMMON SHARES
Basic Shares Outstanding 39.45M
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q2 2018 2017 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $720.0K $1.280M $1.980M
YoY Change -48.2% -35.35% 1423.08%
Cash & Equivalents $723.4K $1.280M $2.038M
Short-Term Investments
Other Short-Term Assets $60.00K $30.00K $80.00K
YoY Change 0.0% -62.5% -27.27%
Inventory $9.905K $0.00 $22.67K
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $798.0K $1.300M $2.084M
YoY Change -45.27% -37.5% 694.38%
LONG-TERM ASSETS
Property, Plant & Equipment $6.384K $10.00K $27.00K
YoY Change -65.28% -66.67% -38.94%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $147.0K $160.0K $209.4K
YoY Change -23.25% -23.81% 4.55%
TOTAL ASSETS
Total Short-Term Assets $798.0K $1.300M $2.084M
Total Long-Term Assets $147.0K $160.0K $209.4K
Total Assets $945.0K $1.460M $2.294M
YoY Change -42.71% -36.24% 395.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $170.0K $120.0K $160.0K
YoY Change -10.53% -25.0% -5.88%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $480.0K $510.0K $890.0K
YoY Change -5.88% -42.7% 12.66%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $705.3K $730.0K $1.823M
YoY Change -29.7% -59.89% 43.26%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $705.3K $730.0K $1.823M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $705.3K $730.0K $1.823M
YoY Change -29.7% -59.89% 43.26%
SHAREHOLDERS EQUITY
Retained Earnings -$4.033M -$1.884M
YoY Change 64.62% 48.74%
Common Stock $396.6K $231.6K
YoY Change 14.39% 5.66%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$239.7K $730.0K $470.8K
YoY Change
Total Liabilities & Shareholders Equity $945.0K $1.460M $2.294M
YoY Change -42.71% -36.24% 395.78%

Cashflow Statement

Concept 2019 Q2 2018 2017 Q4
OPERATING ACTIVITIES
Net Income -$453.5K -$1.339M -$210.0K
YoY Change 27.71% 116.83% -8.7%
Depreciation, Depletion And Amortization $17.90K
YoY Change 3.94%
Cash From Operating Activities -$320.0K -$1.009M -$350.0K
YoY Change 3.23% 108.27% 288.89%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $4.908K $10.00K
YoY Change -80.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 -$7.277K -$10.00K
YoY Change -85.18% -80.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 255.0K 2.200M
YoY Change -89.54% 2100.0%
NET CHANGE
Cash From Operating Activities -320.0K -1.009M -350.0K
Cash From Investing Activities 0.000 -7.277K -10.00K
Cash From Financing Activities 0.000 255.0K 2.200M
Net Change In Cash -320.0K -761.5K 1.840M
YoY Change 3.23% -139.99% -4700.0%
FREE CASH FLOW
Cash From Operating Activities -$320.0K -$1.009M -$350.0K
Capital Expenditures $0.00 $4.908K $10.00K
Free Cash Flow -$320.0K -$1.014M -$360.0K
YoY Change 3.23% 109.28% 157.14%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
115313
CY2017 amar Adjustments To Additional Paid In Capital Subscription Agreement
AdjustmentsToAdditionalPaidInCapitalSubscriptionAgreement
1608574
CY2018 amar Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
0
CY2017 amar Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
0
CY2018Q4 amar Common Stock Shares Outstanding And Reserved
CommonStockSharesOutstandingAndReserved
47973355
CY2018Q4 amar Deferred Tax Assets Liabilities Gross
DeferredTaxAssetsLiabilitiesGross
5082000
CY2017Q4 amar Deferred Tax Assets Liabilities Gross
DeferredTaxAssetsLiabilitiesGross
4801000
CY2018 amar Dividends Payable Reversed
DividendsPayableReversed
34280
CY2017 amar Dividends Payable Reversed
DividendsPayableReversed
CY2018Q4 amar Finitelived Intangible Assets Amortization Expense After Year Four
FinitelivedIntangibleAssetsAmortizationExpenseAfterYearFour
104108
CY2018Q2 dei Entity Public Float
EntityPublicFloat
8681840
CY2018 dei Entity Shell Company
EntityShellCompany
false
CY2018 dei Entity Small Business
EntitySmallBusiness
true
CY2018 amar Increase Decrease In Accrued Interest Related Party
IncreaseDecreaseInAccruedInterestRelatedParty
206
CY2017 amar Increase Decrease In Accrued Interest Related Party
IncreaseDecreaseInAccruedInterestRelatedParty
CY2018Q4 amar Notes Payable Convertible Related Parties
NotesPayableConvertibleRelatedParties
513356
CY2018Q4 amar Notes Payable Convertible Related Parties Classified Current
NotesPayableConvertibleRelatedPartiesClassifiedCurrent
513356
CY2017Q4 amar Notes Payable Convertible Related Parties Classified Current
NotesPayableConvertibleRelatedPartiesClassifiedCurrent
886481
CY2018 amar Proceeds From Convertible Notes Payable Related Party Debt
ProceedsFromConvertibleNotesPayableRelatedPartyDebt
CY2017 amar Proceeds From Convertible Notes Payable Related Party Debt
ProceedsFromConvertibleNotesPayableRelatedPartyDebt
95000
CY2018 amar Proceeds Received For Stock Subscription
ProceedsReceivedForStockSubscription
CY2017 amar Proceeds Received For Stock Subscription
ProceedsReceivedForStockSubscription
1421074
CY2018 amar Repayments Of Convertible Notes Payable Related Party Debt
RepaymentsOfConvertibleNotesPayableRelatedPartyDebt
195000
CY2017 amar Repayments Of Convertible Notes Payable Related Party Debt
RepaymentsOfConvertibleNotesPayableRelatedPartyDebt
CY2018 amar Reversal Of Dividends On Preferred Stock
ReversalOfDividendsOnPreferredStock
34280
CY2018 amar Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Discount Rate
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedDiscountRate
0.0296
CY2018 amar Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm
P5Y
CY2018 amar Stock Issued During Period Value Debt
StockIssuedDuringPeriodValueDebt
178125
CY2018 amar Stock Issued During Period Value Subscription
StockIssuedDuringPeriodValueSubscription
CY2018 amar Stock Issued For Accrued Liabilities
StockIssuedForAccruedLiabilities
116250
CY2017 amar Stock Issued For Accrued Liabilities
StockIssuedForAccruedLiabilities
CY2018 amar Stock Issued For Advances From Investors
StockIssuedForAdvancesFromInvestors
721035
CY2017 amar Stock Issued For Advances From Investors
StockIssuedForAdvancesFromInvestors
187500
CY2018 amar Stock Issued For Subscription
StockIssuedForSubscription
85791
CY2017 amar Stock Issued For Subscription
StockIssuedForSubscription
CY2018 amar Write Off Of Patent Costs
WriteOffOfPatentCosts
16000
CY2018 dei Amendment Flag
AmendmentFlag
false
CY2018 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2018 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
CY2018 dei Document Period End Date
DocumentPeriodEndDate
2018-12-31
CY2018 dei Document Type
DocumentType
10-K
CY2019Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
39453524
CY2018 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2017Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
159300
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
91901
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
74003
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3527238
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2123205
CY2017 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
28200
CY2018 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
100366
CY2018 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
27765
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2018 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
7320
CY2018 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
CY2017 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
28200
CY2018 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
38296
CY2017 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
22773
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3458214
CY2018Q4 us-gaap Assets
Assets
1463700
CY2017Q4 us-gaap Assets
Assets
2293834
CY2018Q4 us-gaap Assets Current
AssetsCurrent
1303234
CY2017Q4 us-gaap Assets Current
AssetsCurrent
2084451
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1276654
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2038150
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
134125
CY2018 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-761496
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1904025
CY2018Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
39117524
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23156563
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
39117524
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23156563
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
391175
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
231565
CY2017 us-gaap Deferred Compensation Arrangement With Individual Fair Value Of Shares Issued
DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued
106250
CY2018 us-gaap Deferred Compensation Arrangement With Individual Fair Value Of Shares Issued
DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued
116250
CY2018 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Concentration of Credit Risk</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Financial instruments that potentially subject the Company to significant concentration of credit risk consist principally of cash. The Company has cash balances in a single financial institution which, from time to time, could exceed the federally insured limit of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$250,000.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No</div> loss has been incurred related to this concentration of cash.</div></div></div></div></div></div></div></div></div>
CY2018 us-gaap Cost Of Revenue
CostOfRevenue
64877
CY2017 us-gaap Cost Of Revenue
CostOfRevenue
60316
CY2018 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
178125
CY2017 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
CY2017 us-gaap Deferred Compensation Arrangement With Individual Shares Issued
DeferredCompensationArrangementWithIndividualSharesIssued
413420
CY2018 us-gaap Deferred Compensation Arrangement With Individual Shares Issued
DeferredCompensationArrangementWithIndividualSharesIssued
451480
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
5082000
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
4801000
CY2018Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
CY2017Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
5082000
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
4801000
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
5082000
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
4801000
CY2018Q4 us-gaap Deferred Tax Liabilities Gross Current
DeferredTaxLiabilitiesGrossCurrent
CY2017Q4 us-gaap Deferred Tax Liabilities Gross Current
DeferredTaxLiabilitiesGrossCurrent
CY2018 us-gaap Depreciation
Depreciation
17895
CY2017 us-gaap Depreciation
Depreciation
17217
CY2018 us-gaap Depreciation And Amortization
DepreciationAndAmortization
56194
CY2017 us-gaap Depreciation And Amortization
DepreciationAndAmortization
39990
CY2018Q4 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
104952
CY2017Q4 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
777258
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2018Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1775222
CY2018 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P4Y273D
CY2018Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
11582
CY2018Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
9434
CY2018Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
9838
CY2018Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
11494
CY2018Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
146456
CY2018Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
146456
CY2017Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
182386
CY2018 us-gaap Gross Profit
GrossProfit
12847
CY2017 us-gaap Gross Profit
GrossProfit
190612
CY2018 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2017 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-9461
CY2018 us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
CY2017 us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
-124833
CY2018 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-22666
CY2017 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
7966
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-67400
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-89939
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2018 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
281000
CY2017 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-2800000
CY2018 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
CY2017 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
3010000
CY2018 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-281000
CY2017 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-210000
CY2018 us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2017 us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2018 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
54844
CY2018 us-gaap Interest Expense
InterestExpense
3963
CY2017 us-gaap Interest Expense
InterestExpense
37612
CY2018 us-gaap Interest Paid Net
InterestPaidNet
3818
CY2017 us-gaap Interest Paid Net
InterestPaidNet
29318
CY2018Q4 us-gaap Inventory Net
InventoryNet
CY2017Q4 us-gaap Inventory Net
InventoryNet
22666
CY2018 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
27765
CY2017 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
10688
CY2018Q4 us-gaap Liabilities
Liabilities
733621
CY2017Q4 us-gaap Liabilities
Liabilities
1823039
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1463700
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2293834
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
733621
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1823039
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
254979
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2437689
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7277
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-49096
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1009198
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-484568
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-1338639
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-617375
CY2018 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3
CY2018 us-gaap Open Tax Year
OpenTaxYear
2018 2017 2016
CY2018 us-gaap Operating Expenses
OperatingExpenses
1347523
CY2017 us-gaap Operating Expenses
OperatingExpenses
770375
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-1334676
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-579763
CY2018Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
24204000
CY2018 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
2369
CY2017 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
49096
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4908
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
26580
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
23635
CY2018 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
401250
CY2017 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
144357
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
CY2018 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
48729
CY2017 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
777258
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
105911
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
101000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14010
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
26997
CY2018 us-gaap Revenues
Revenues
77724
CY2017 us-gaap Revenues
Revenues
250928
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
32591
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3188334
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1883975
CY2018 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1314932
CY2017 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
770375
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
100366
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
106250
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
2.76
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.38
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.38
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y
CY2018Q3 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
539447
CY2018 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
18852
CY2017 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
10688
CY2017 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
144357
CY2018 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1122285
CY2017 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
106250
CY2018 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
116250
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
-809899
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
470795
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
730079
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
730079
CY2017Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
470795
CY2018 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Use of Estimates</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</div></div></div></div></div></div></div></div></div>
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
35643804
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
22663476

Files In Submission

Name View Source Status
0001014763-19-000004-index-headers.html Edgar Link pending
0001014763-19-000004-index.html Edgar Link pending
0001014763-19-000004.txt Edgar Link pending
0001014763-19-000004-xbrl.zip Edgar Link pending
amar-20181231.xml Edgar Link completed
amar-20181231.xsd Edgar Link pending
amar-20181231_cal.xml Edgar Link unprocessable
amar-20181231_def.xml Edgar Link unprocessable
amar-20181231_lab.xml Edgar Link unprocessable
amar-20181231_pre.xml Edgar Link unprocessable
exhibit10-72_12312018.htm Edgar Link pending
exhibit10-73_12312019.htm Edgar Link pending
exhibit10-74_12312018.htm Edgar Link pending
exhibit10-75_12312018.htm Edgar Link pending
exhibit31-1a_12312018.htm Edgar Link pending
exhibit31-1b_12312018.htm Edgar Link pending
exhibit33-1_12312018.htm Edgar Link pending
exhibit99-1_12312018.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10k_12312018.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending